IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as…
13 analysts rate IDXX Buy on consensus.
Consensus price target: $698.00 (+24.56% upside from $560.38)
| Insider | Date | Transaction | Shares | Value |
|---|---|---|---|---|
| Hunt Nimrata Executive Vice President | Mar 3, 2026 | Sale | 1,758 | $1.12M |
| MAZELSKY JONATHAN JAY director, President and CEO | Feb 26, 2026 | Sale | 2,860 | $1.88M |
| MAZELSKY JONATHAN JAY director, President and CEO | Feb 26, 2026 | Sale | 3,660 | $2.41M |
| MAZELSKY JONATHAN JAY director, President and CEO | Feb 26, 2026 | Sale | 2,859 | $1.89M |
| MAZELSKY JONATHAN JAY director, President and CEO | Feb 26, 2026 | Sale | 1,200 | $793.32K |
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $4.3B | +10.42% | $1.06B |
| 2024 | $3.9B | +6.46% | $887.87M |
| 2023 | $3.66B | +8.72% | $845.04M |
Stock data for IDXX: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics